Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve

Mersin Training and Research Hospital

Status: Completed

Conditions: Meralgia Paresthetica

Study type: Observational

Funder types: Other

Identifiers

NCT06187883

MersinTRHlfcn

Details and patient eligibility

About

In the current retrospective cohort study, conducted by both pain specialists and neurophysiologists, the primary outcome was to search for the effect of obesity on the efficacy of PRF of LFCN in refractory MP for 6 months. Secondary outcomes were to identify the clinical and diagnostic features of the MP.

Full description

In the current retrospective cohort study, conducted by both pain specialists and neurophysiologists, the primary outcome was to search for the effect of obesity on the efficacy of PRF of LFCN in refractory MP for 6 months. Secondary outcomes were to identify the clinical and diagnostic features of the MP.

Enrollment: 30 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• older than 18 years treated with PRF neuromodulation of LFCN for MP
• followed up at least 6 months in the pain clinic of the tertiary hospital between January 2020 and August 2023.

Exclusion criteria

• inadequate follow-up or missing documentation
• If a new analgesic drug was prescribed during the follow-up period that could affect the evaluation of outcomes, the patients were also excluded.
• Patients who missed appointments, or were unable to communicate with; were not included in the study.
• Patients with secondary entrapment neuropathy (e.g., diabetes, inflammatory arthritis, hypothyroidism), malignancy, pregnancy, skin infection in the inguinal region or dermatitis, lumbar radiculopathy, polyneuropathy, and cardiac pacemakers were excluded.
• In the SSEP analysis, when the latency of LFCN was not evaluated in both sides, these patients were not also included in the study.

Trial design

30 participants in 1 patient group

1

Description:

patients treated with PRFT